Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cousins Properties | CUZ | Nov 27, 2024 | 31.94 | +0.57 |
Covenant Logistics Group | CVLG | Nov 27, 2024 | 57.91 | -1.51 |
Coya Therapeutics | COYA | Nov 27, 2024 | 6.65 | +4.23 |
CPS Technologies | CPSH | Nov 27, 2024 | 1.51 | +2.72 |
CRA International | CRAI | Nov 27, 2024 | 194.14 | -2.59 |
Cracker Barrel Old Country Store | CBRL | Nov 27, 2024 | 52.76 | +1.56 |
Crane Company | CR | Nov 27, 2024 | 181.60 | -1.82 |
Crane NXT | CXT | Nov 27, 2024 | 62.77 | -0.74 |
Crawford & Company A | CRD-A | Nov 27, 2024 | 11.69 | -0.76 |
Crawford & Company B | CRD-B | Nov 27, 2024 | 10.98 | +0.46 |
Creative Media & Community Trust | CMCT | Nov 27, 2024 | 0.25 | +2.08 |
Creative Medical Technology | CELZ | Nov 27, 2024 | 2.65 | -1.49 |
Creative Realities | CREX | Nov 27, 2024 | 3.18 | -2.45 |
Credicorp | BAP | Nov 27, 2024 | 191.29 | -0.73 |
Credit Acceptance | CACC | Nov 27, 2024 | 494.24 | +2.28 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Nov 27, 2024 | 27.00 | 0.00 |
Credit Suisse Ag | GLDI | Nov 27, 2024 | 153.33 | +0.38 |
Credit Suisse Ag | SLVO | Nov 27, 2024 | 76.50 | -1.16 |
Credit Suisse Asset Management Income Fund | CIK | Nov 27, 2024 | 2.95 | -1.67 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Nov 27, 2024 | 63.92 | +0.35 |
Credit Suisse High Yield Bond Fund | DHY | Nov 27, 2024 | 2.18 | 0.00 |
Credo Technology | CRDO | Nov 27, 2024 | 45.71 | -2.06 |
Crescent Capital BDC | CCAP | Nov 27, 2024 | 19.29 | +0.10 |
Crescent Energy | CRGY | Nov 27, 2024 | 14.81 | +1.79 |
Cresud A ADR | CRESY | Nov 27, 2024 | 11.88 | -3.73 |
Crexendo | CXDO | Nov 27, 2024 | 5.26 | -1.13 |
CRH | CRH | Nov 27, 2024 | 101.94 | -0.90 |
Cricut A | CRCT | Nov 27, 2024 | 5.16 | -0.19 |
Crinetics Pharmaceuticals | CRNX | Nov 27, 2024 | 57.67 | +1.59 |
CRISPR Therapeutics | CRSP | Nov 27, 2024 | 50.84 | +3.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.